Interview with Amit Dror: Nano Dimension

blank

An entrepreneur, Amit Dror Co-Founder and CSO of Nano Dimension, the world’s leading additive electronics provider. From 2014 to 2020 was CEO of the Nano Dimension. Started in the Telecoms industry and spent a decade at ECI and Comverse, before co-founding his first start-up, Eternegy Ltd in 2010, which focused on solar power and environmentally friendly electricity generation. Co-founded the Milk & Honey Whiskey Distillery. Israel’s first ever whisky distillery, the company produces each whisky to the highest standards. It was soon recognized by Forbes and nominated as one to try. It was not long before Amit recognized a further niche in the marketplace – this time with additive electronics, and he co-founded Nano Dimension in 2012. Amit currently serves as Nano Dimension’s CEO.

Recognized as the world’s leading additive electronics provider, and a company that is disrupting, reshaping, and defining the future of how cognitive, connected electronic products are made.

Amit is keenly aware that the Nano Dimension technology will soon impact the future of every industry from medical devices and telecommunications to the defense, aerospace, and automotive industries, and will heavily influence our personal futures in years to come. 

Nano Dimension has an unmatched product portfolio including the unrivaled and award-winning DragonFly™ Pro System for Precision Additive Manufacturing of Printed Electronics. “This machine essentially prints simultaneously Nano-metal and complex-polymer which has never been done before. This means that electronics can be produced more quickly and securely in-house, with lower costs and disruptive designs than ever before.”

“We are enabling the electronics industry to catch up with the fast-paced world of today – and print electronics immediately and in-house. This makes our solution a cost-effective, highly efficient, and accessible way to produce the much-needed electronics proliferating through our lives today – in smaller sizes and even different shapes.”

Amit spoke at our 3D Printed Bioelectronics event in 2021.

Jenny: When was the first encounter you had with 3D Printing? What was that experience like? What were you thinking at that moment?

Amit: My first encounter with 3D printing was when I was a teenager in the early 90s. I recall watching on TV an artist making a sculpture of a head. Actually, it was not a truly additive manufacturing process but a subtractive process of a laser carving on Styrofoam. I was truly amazed by how the shape of the head was created like magic. 30 years later when I first encountered Bioprinting and even had the opportunity to lead a POC project at Nano Dimension in which we successfully printed stem cells. This field is mind-blowing.

Jenny: What inspired you to start your journey in 3D Printing (or Bioprinting)?

Amit: My ex-partner, Sharon Fima, another co-founder of Nano Dimension and currently CEO of meaTech 3D. It was his idea to combine Nano materials with polymers in order to 3D print electronics boards and devices. But really the thought that we could 3D print complex circuit boards was at the core of the inspiration to get on this journey of Nano Dimension.

Jenny: Who inspired you the most along this journey in 3D Printing (or Bioprinting)?

Amit: Several people come to mind: I learned a lot from Avi Reichental, that for several years was the chairman of Nano Dimension and my mentor when I was the CEO of Nano Dimension.  Avi is definitely one of the most significant influencers in the AM industry. The current CEO of Nano Dimension, Yoav Stern, is highly inspiring and I learn from him how to scale up from a start-up to a market-leading corporate.

Jenny: What motivates you the most for your work? 

Amit: The people and applications that I see when meeting with our customers. I’m amazed and inspired by how our AME technology changes the way they design and produce advanced electronics components.

Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions? 

Amit: In the field of advanced materials and hardware, progress takes time. Normally it takes years. The biggest obstacle is to keep moving forward when progress is sometimes slow. With that challenge comes the need to be patient, efficient, and a greater need to raise money. At Nano Dimension we managed, after years of hard work, to convince the market that our technology is viable and that the disruption we are offering to the electronics industry is significant. That enabled us to raise money.

Jenny: What do you think is (are) the biggest challenge(s) in 3D Printing (or Bioprinting)? What do you think the potential solution(s) is (are)?

Amit: The fact that research in these fields is always needed and requires long periods. I’d put my finger on funding as the key challenge for most companies. Working closely with customers from an early stage is in many cases the best way to keep in focus and identify better the market segments. When customer needs are clear, the product needs are clear and with that, it is easier to identify and optimize business needs.

Jenny: If you are granted three wishes by a higher being, what would they be? 

Amit: Be happy, have my loved ones with me and have peace on Earth.

Jenny: What advice would you give to a smart driven college student in the “real world”? What bad advice you heard should they ignore?

Amit: Don’t start something you are not truly passionate about. Find multiple mentors, listen carefully, and take your own decisions. Try to avoid repeating past mistakes. You are about to take many decisions moving forward – Some of them will be wrong. That’s ok as long as you debrief yourself and accept constructive criticism from others. Self-improvement as a goal would help you to succeed in the long run. It’s a very long run.

Enabling Futuristic Bioelectronics With Bioprinting: Beyond the Obvious

3D Printing for the Human Organ Shortage: Putting Bio back into Bioprinting

3D Bioprinting: Chiasm of Art, Design, Science, Technology, and Evolution

Comments